These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 10435719

  • 1. Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.
    Xiang M, Zaccone P, Di Marco R, Harris R, Magro G, Di Mauro M, Meroni PL, Garotta G, Nicoletti F.
    Autoimmunity; 1999; 30(2):71-80. PubMed ID: 10435719
    [Abstract] [Full Text] [Related]

  • 2. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.
    Campbell IL, Kay TW, Oxbrow L, Harrison LC.
    J Clin Invest; 1991 Feb; 87(2):739-42. PubMed ID: 1899431
    [Abstract] [Full Text] [Related]

  • 3. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S, Penna G, Gregori S, Gately MK, Adorini L.
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [Abstract] [Full Text] [Related]

  • 4. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 5. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M, Overbergh L, Mathieu C, Kolb H, Martin S.
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [Abstract] [Full Text] [Related]

  • 6. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y, Prud'homme GJ.
    J Gene Med; 1999 Oct; 1(6):415-23. PubMed ID: 10753067
    [Abstract] [Full Text] [Related]

  • 7. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.
    J Immunol; 1999 Sep 01; 163(5):2960-8. PubMed ID: 10453045
    [Abstract] [Full Text] [Related]

  • 8. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V, Elias D, Reshef T, Cohen IR.
    J Autoimmun; 1998 Feb 01; 11(1):73-81. PubMed ID: 9480725
    [Abstract] [Full Text] [Related]

  • 9. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1996 Jun 01; 9(3):331-9. PubMed ID: 8816968
    [Abstract] [Full Text] [Related]

  • 10. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR.
    J Autoimmun; 1999 Dec 01; 13(4):383-92. PubMed ID: 10585754
    [Abstract] [Full Text] [Related]

  • 11. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.
    Nat Med; 2001 Sep 01; 7(9):1057-62. PubMed ID: 11533711
    [Abstract] [Full Text] [Related]

  • 12. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse.
    Zaccone P, Phillips J, Conget I, Cooke A, Nicoletti F.
    Clin Immunol; 2005 Apr 01; 115(1):74-9. PubMed ID: 15870024
    [Abstract] [Full Text] [Related]

  • 13. MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Panerai AE, Nicoletti F, Sacedote P, Arvidsson L, Conget I, Gomis R, Bartorelli A, Sandler S.
    Diabetologia; 2001 Jul 01; 44(7):839-47. PubMed ID: 11508268
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 15. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT, Liao JH, Lin YC, Chang HY, Wu SF, Chang TH, Kung JT, Hsieh SL, McDevitt H, Sytwu HK.
    J Autoimmun; 2005 Nov 01; 25(3):181-92. PubMed ID: 16263243
    [Abstract] [Full Text] [Related]

  • 16. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.
    Prud'homme GJ, Chang Y.
    Gene Ther; 1999 May 01; 6(5):771-7. PubMed ID: 10505100
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
    Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown DR.
    J Immunol; 1996 May 01; 156(9):3521-7. PubMed ID: 8617981
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.